SomnoMed posts record Q4 and delivers on FY22 revenue guidance
Dental News and Technology
JULY 28, 2022
PLANO, Texas , July 26, 2022 /PRNewswire/ -- SomnoMed Limited (ASX "SOM", or the Company), a leading company in the provision of oral appliance treatment solutions for sleep-related breathing disorders and obstructive sleep apnea ('OSA'), is pleased to provide its quarterly activities report for the period ended 30 June 2022 (Q4 FY22). SomnoMed posts record Q4 and delivers on FY22 revenue guidance.
Let's personalize your content